The global Geriatric Medicines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Geriatric Medicines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Geriatric Medicines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Geriatric Medicines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Geriatric Medicines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
AstraZeneca plc
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc.
Merck & Company Inc.
Novartis AG
Pfizer, Inc.
Sanofi S.A

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others

Segment by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others